Hyperion DeFi Reports No Revenue and $12.2 Million Net Loss for First Half of 2025

Hyperion DeFi, Inc. has reported significant financial developments in its latest 10-Q filing for the quarter ending June 30, 2025. The company, which transitioned from Eyenovia, Inc., recorded no revenue for the three months ended June 30, 2025, a decrease from $22,625 in the same period last year. For the six months ending June 30, 2025, revenue totaled $14,720, down from $27,618 in the prior year. The company reported a net loss of $12.2 million for the first half of 2025, a notable improvement from a loss of $22.0 million during the same period in 2024.

The financial position of Hyperion DeFi has improved significantly, with total assets rising to $55.7 million as of June 30, 2025, compared to $3.7 million at the end of 2024. This increase is largely attributed to the acquisition of $45.5 million in HYPE digital tokens and a substantial rise in cash and cash equivalents, which reached $7.5 million, up from $2.1 million at the end of 2024. The company’s liabilities also decreased, with total liabilities reported at $18.3 million, down from $16.8 million at the end of the previous fiscal year.

Strategically, Hyperion DeFi has made significant moves, including a private placement that raised approximately $50 million through the issuance of Series A Non-Voting Convertible Preferred Stock and associated warrants. This capital is intended to support the company's treasury strategy focused on HYPE tokens. Additionally, the company has been developing its proprietary Optejet User Filled Device, aimed at enhancing the delivery of ophthalmic medications, which is expected to be registered with the FDA soon.

Operationally, Hyperion DeFi has seen a reduction in its workforce, which has contributed to a decrease in research and development expenses, down to $1.3 million for the first half of 2025 from $9.0 million in the same period last year. The company has also reported a working capital deficit of $923,797 as of June 30, 2025, but has plans to mitigate this through cost reductions and potential future financings. The company’s stockholders’ equity improved to $37.4 million, indicating a recovery from previous deficits.

Looking ahead, Hyperion DeFi aims to stabilize its financial position and enhance its operational efficiency. The management has expressed confidence in its ability to navigate the current market conditions and is focused on the successful registration of the Optejet device, which could lead to increased revenue streams. The company is also exploring additional funding avenues, including the potential sale of HYPE tokens, to support its ongoing operations and strategic initiatives.